Science news articles about 'randi hagerman'

... with XXYY syndrome that may be better addressed with more targeted therapies," said Randi Hagerman, medical director of the M.I.N.D. Institute and senior author of the study. "Our ...

... "These patients don't have the advantage of targeted treatments and specific therapies," Randi Hagerman said. The families of these patients are also at risk because the mutations are passed on from ...